Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDEdesa Biotech Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 1 | -$0.26 | -$0.26 | -$0.26 |
| Q2 2026 | 1 | -$0.55 | -$0.55 | -$0.55 |
| Q3 2026 | 1 | -$0.57 | -$0.57 | -$0.57 |
Edesa Biotech Inc Earnings Date And Information
Edesa Biotech Inc last posted its earnings results on Friday, February 13th, 2026. The company reported $-0.28 earnings per share for the quarter, missing analysts' consensus estimates of $-0.28 by $0. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Edesa Biotech Inc has generated $-1 earnings per share over the last year ($-1.27 diluted earnings per share) and currently has a price-to-earnings ratio of -13.54. Edesa Biotech Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Edesa Biotech Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 02/13/2026 | Q1 2026 | -$0.28 | -$0.28 | 0 | $0 | $0 |
| 12/12/2025 | Q4 2025 | -$0.27 | -$0.32 | -0.05 | $0 | $0 |
| 08/08/2025 | Q3 2025 | -$0.26 | -$0.25 | 0.01 | N/A | $0 |
| 05/14/2025 | Q2 2025 | -$0.30 | -$0.30 | 0 | N/A | $0 |
| 02/14/2025 | Q1 2025 | -$0.31 | -$0.48 | -0.17 | N/A | $0 |
| 12/20/2024 | Q4 2024 | N/A | -$0.30 | N/A | N/A | $0 |
| 08/09/2024 | Q3 2024 | -$0.58 | -$0.52 | 0.06 | N/A | $0 |
| 05/10/2024 | Q2 2024 | -$0.69 | -$0.58 | 0.11 | N/A | $0 |
| 02/09/2024 | Q1 2024 | -$1.21 | -$0.54 | 0.67 | N/A | $0 |
| 12/15/2023 | Q4 2023 | -$0.71 | -$0.57 | 0.14 | N/A | $-1,118,100 |
| 08/09/2023 | Q3 2023 | -$1.19 | -$0.68 | 0.51 | N/A | $0 |
| 05/11/2023 | Q2 2023 | -$1.19 | -$0.82 | 0.37 | N/A | $0 |
| 02/10/2023 | Q1 2023 | -$1.33 | -$0.87 | 0.46 | N/A | $1.12 M |
| 03/27/2023 | Q4 2022 | N/A | -$1.22 | N/A | N/A | $0 |
| 08/12/2022 | Q3 2022 | -$2.52 | -$2.61 | -0.09 | N/A | $0 |
| 05/13/2022 | Q2 2022 | -$2.59 | -$2.31 | 0.28 | N/A | $0 |
| 02/14/2022 | Q1 2022 | -$2.80 | -$2.30 | 0.5 | N/A | $0 |
| 12/28/2021 | Q4 2021 | -$2.59 | -$1.95 | 0.64 | N/A | $-3,511,315 |
| 08/13/2021 | Q3 2021 | -$2.24 | -$2.51 | -0.27 | N/A | $0 |
| 05/14/2021 | Q2 2021 | -$2.10 | -$1.36 | 0.74 | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Edesa Biotech Inc Earnings: FAQ's
The conference call for Edesa Biotech Inc's latest earnings report can be listened to online.
The conference call transcript for Edesa Biotech Inc's latest earnings report can be read online.
Edesa Biotech Inc (:EDSA) has a recorded net income of $-7,185,523.Edesa Biotech Inc has generated $-1.27 earnings per share over the last four quarters.
Edesa Biotech Inc (:EDSA) has a price-to-earnings ratio of -13.54 and price/earnings-to-growth ratio is -0.26.